EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C-terminally clustered UGDH hypomorphic variants reveal subtle mechanisms of cellular and developmental disruption

Hali Harwood, Brenna M Zimmer, Asher R Utz, Myrrhe Venema, Emily Allego, Sydney S Skirboll, Autumn Harding, Jeffrey R Enders, Sarah Grantham-Hill, Frances Elmslie, Yong-Ru Ly, Antonia Clarke und 8 weitere

Matrix Biology · 2026-06 · 146 · 102011

DOI: 10.1016/j.matbio.2026.102011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Matrix Biology, 2026-06. Verfasst von Hali Harwood und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695, USA. Hauptthemen laut MEDLINE: Uridine Diphosphate Glucose Dehydrogenase, Mutation, Missense, Congenital Disorders of Glycosylation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Jamuar syndrome (Developmental and Epileptic Encephalopathy 84, OMIM# 618792) is a rare autosomal recessive congenital disorder of glycosylation (CDG), caused by variations in the gene encoding UDP-glucose dehydrogenase (UGDH). Although a number of UGDH variants have been functionally characterized, there is an incomplete catalogue of variants and their impacts on development. Here, we present functional data characterizing new missense variants from three unrelated individuals who were D379N homozygous, Y356D homozygous, and compound heterozygous A436G/R442W, respectively. UGDH activity was low to undetectable in patient-derived fibroblasts bearing either UGDH D379N or UGDH A436G/R442W, relative to WT fibroblasts, despite robust UGDH expression in both. Measurement of nucleotide sugar levels revealed a significant decrease in the UGDH product, UDP-glucuronate, and consequent reductions in hyaluronan production, Notch1 levels, and rate of O-and N-linked glycan synthesis, consistent with loss of UGDH activity. These features support the designation of UGDH D379N and UGDH A436G as causative variants in Jamuar Syndrome. We expressed and purified UGDH D379N, A436G, R442W, R443H, and Y356D variants to examine underlying molecular mechanisms. Kinetic properties and structural stability assays selectively revealed significant changes in conformational dynamics that manifested strong effects on endogenous inhibitor binding and product inhibition. The results suggest that alterations to the C-terminal domain impact activity of UGDH in cells by impairing its cofactor exchange rate and diminishing quaternary association. These effects would be maximized at developmental milestones in which hypoxia drives morphological change, since NADH accumulation would then decrease glycosaminoglycan production, with profound developmental consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uridine Diphosphate Glucose DehydrogenaseMutation, MissenseCongenital Disorders of GlycosylationHumansFibroblastsGlycosylationHyaluronic AcidUridine Diphosphate Glucuronic Acid

Stichwörter der Autor:innen

Congenital disorders of glycosylationDevelopmental epileptic encephalopathyGlycosaminoglycanHyaluronanUDP-glucose dehydrogenaseenzyme kinetics

Substanzen

Uridine Diphosphate Glucose DehydrogenaseHyaluronic AcidUridine Diphosphate Glucuronic Acid

Autor:innen und Institutionen

  • Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695, USA.
  • Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Molecular Education, Technology and Research Innovation Center, North Carolina State University, Raleigh, NC 27695, USA.
  • South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Synnovis Biochemical Genetics, Guy's Hospital, London, UK.
  • Department of Paediatric Neurology, St George's University Hospitals NHS Foundation Trust, London, UK.

Förderung

  • National Institutes of Health

Zitieren

APA

Harwood, H., Zimmer, B. M., Utz, A. R., Venema, M., Allego, E., Skirboll, S. S., Harding, A., Enders, J. R., Grantham-Hill, S., Elmslie, F., Ly, Y. R., Clarke, A., Xu, M., Tan, H. J., Stals, K., Jamuar, S. S., Barakat, T. S., Makris, T. M., Barycki, J. J., & Simpson, M. A. (2026). C-terminally clustered UGDH hypomorphic variants reveal subtle mechanisms of cellular and developmental disruption. Matrix Biology, 146, 102011. https://doi.org/10.1016/j.matbio.2026.102011

Vancouver

Harwood H, Zimmer BM, Utz AR, Venema M, Allego E, Skirboll SS, et al. C-terminally clustered UGDH hypomorphic variants reveal subtle mechanisms of cellular and developmental disruption. Matrix Biology. 2026;146:102011. doi:10.1016/j.matbio.2026.102011

BibTeX
@article{Harwood2026,
  author = {Harwood, Hali and Zimmer, Brenna M and Utz, Asher R and Venema, Myrrhe and Allego, Emily and Skirboll, Sydney S and Harding, Autumn and Enders, Jeffrey R and Grantham-Hill, Sarah and Elmslie, Frances and Ly, Yong-Ru and Clarke, Antonia and Xu, Maria and Tan, Hui Jeen and Stals, Karen and Jamuar, Saumya Shekhar and Barakat, Tahsin Stefan and Makris, Thomas M and Barycki, Joseph J and Simpson, Melanie A},
  title = {C-terminally clustered UGDH hypomorphic variants reveal subtle mechanisms of cellular and developmental disruption},
  journal = {Matrix Biology},
  year = {2026},
  volume = {146},
  pages = {102011},
  doi = {10.1016/j.matbio.2026.102011}
}
Kostenlos starten →